WHAT WE DO.
lntelliSyn is among the leading independent providers of drug discovery support in North America. The company was formed by members of the AstraZeneca leadership team following the site closure in Montreal. Our experienced scientists have in-depth understanding of all aspects of medicinal chemistry and the expertise to accelerate drug discovery of clinically viable, maximally de-risked drug candidates.
Our state-of-the-art facility in Montreal is fully equipped to support all aspects of drug discovery, from hit ID to clinical candidate nomination. We provide synthetic, computational, analytical, and in vitro and in vivo biology support.
YOUR CAN TRUST
IntelliSyn delivers excellence, innovation, and efficiency.
More than 75% of our scientists have Ph.D. degrees and post-doctoral work at leading Universities in the US, Canada, or Europe. Our lead scientists have 15-25 years of experience within major pharma, including AstraZeneca, Boehringer Ingelheim, and Merck.
You would like to get our full presentation? Simply enter you name and email!